Stille

Stille EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Stille (STIL.ST) as of Oct 24, 2026 is 43.47. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 20.15 — a change of 115.78% (higher).

EV/OCF

43.47

YoY

115.78%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Stille is 2025 43.47 . EV/OCF (Enterprise Value to Operating Cash Flow) of Stille was 2024 20.15 . It decreases by 115.78% higher compared to the previous year.

The Stille EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
114.64 SEK
Jan 1, 2019
60.29 SEK
Jan 1, 2020
76.03 SEK
Jan 1, 2021
224.05 SEK
Jan 1, 2022
50.45 SEK
Jan 1, 2023
37.51 SEK
Jan 1, 2024
20.15 SEK
Jan 1, 2025
43.47 SEK
The Stille EV/OCF history
YEAREV/OCFYoY
43.47+115.78%
20.15-46.29%
37.51-25.63%
50.45-77.48%
224.05+194.68%
76.03+26.11%
60.29-47.41%
114.64+40.57%
81.55+2.31%
79.71-45.14%
145.30-112.47%
-1,164.82—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Stille is 43.47 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Stille changed from 20.15 to 43.47, representing a 115.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Stille since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Stille with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Stille

All Key Metrics — Stille